Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.
Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fract...
Saved in:
Main Authors: | Dongfeng Zhao, Zhenqi Shi, Amy H Warriner, Ping Qiao, Huixian Hong, Yongjun Wang, Xu Feng |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/dc16db73d1cb4e6f8503783122d9df53 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity
by: Sever Belgin, et al.
Published: (2021) -
Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms.
by: Sandra Meidute Abaraviciene, et al.
Published: (2008) -
SYNTHESIS AND SAR STRATEGY OF THIAZOLIDINEDIONE: A NOVEL APPROACH FOR CANCER TREATMENT
by: Rashid,Mohammad, et al.
Published: (2020) -
Differential effects of thiazolidinediones on adipocyte growth and recruitment in Zucker fatty rats.
by: Jennifer MacKellar, et al.
Published: (2009) -
Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis
by: Wen Wang, et al.
Published: (2017)